• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板和白细胞在凝血和纤溶中的作用。

The role of platelets and leukocytes in coagulation and fibrinolysis.

作者信息

Cucuianu M, Trif I

机构信息

Department of Clinical Biochemistry, University of Cluj Medical School.

出版信息

Rev Roum Physiol (1990). 1992 Jan-Jun;29(1-2):33-8.

PMID:1472550
Abstract

After briefly reviewing the literature concerning the role of leukocytes and platelets in coagulation and fibrinolysis, the authors present their own results on the effect of intact platelets and of platelet releasate on tissue plasminogen activator-induced lysis of plasma clots. At a final concentration of 7 IU/ml of tissue plasminogen activator in the clotted mixture, a suspension of intact platelets (110 x 10(6)/ml in final concentration) produced an acceleration of clot lysis, while the thrombin-induced platelet releasate obtained from the same platelet suspension caused an obvious inhibition of fibrinolysis. The respective mean lysis times obtained in 7 experiments were 91 min +/- 7.76 (mean +/- SEM) for the control clots, 65 min +/- 5.8 for the clots containing platelets and 114 min +/- 11.5 for the clots including platelet releasate. The statistical significance versus controls, calculated by paired difference analysis was p < 0.002 and p < 0.001, respectively. The results suggest that in the context of a potent activation of fibrinolysis the platelet surface would enhance the process by favouring the interaction between plasminogen and its activator, while the platelet releasate rich inhibitors would increase the resistance to lysis of the plasma clot.

摘要

在简要回顾了有关白细胞和血小板在凝血和纤维蛋白溶解中作用的文献后,作者展示了他们自己关于完整血小板和血小板释放物对组织纤溶酶原激活物诱导的血浆凝块溶解作用的研究结果。在凝血混合物中组织纤溶酶原激活物的终浓度为7 IU/ml时,完整血小板悬液(终浓度为110×10⁶/ml)可加速凝块溶解,而从相同血小板悬液中获得的凝血酶诱导的血小板释放物则明显抑制纤维蛋白溶解。在7次实验中,对照凝块的平均溶解时间为91分钟±7.76(平均值±标准误),含血小板凝块的平均溶解时间为65分钟±5.8,含血小板释放物凝块的平均溶解时间为114分钟±11.5。通过配对差异分析计算得出,与对照相比的统计学显著性分别为p<0.002和p<0.001。结果表明,在纤维蛋白溶解强力激活的情况下,血小板表面会通过促进纤溶酶原与其激活物之间的相互作用来增强这一过程,而富含抑制剂的血小板释放物会增加血浆凝块对溶解的抵抗力。

相似文献

1
The role of platelets and leukocytes in coagulation and fibrinolysis.血小板和白细胞在凝血和纤溶中的作用。
Rev Roum Physiol (1990). 1992 Jan-Jun;29(1-2):33-8.
2
Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.纤溶酶原激活剂和抗血小板药物联合作用下,富含血小板的纤维蛋白凝块在体外的快速溶解
J Pharmacol Exp Ther. 1991 Dec;259(3):1371-8.
3
Peroxynitrite may affect fibrinolysis via the reduction of platelet-related fibrinolysis resistance and alteration of clot structure.过氧亚硝酸盐可能通过降低血小板相关的纤维蛋白溶解抵抗和改变血栓结构来影响纤维蛋白溶解。
Free Radic Biol Med. 2015 Dec;89:533-47. doi: 10.1016/j.freeradbiomed.2015.09.006. Epub 2015 Oct 8.
4
Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets.血小板释放1型纤溶酶原激活物抑制剂对溶栓作用的减弱。
Thromb Res. 1993 Dec 1;72(5):413-21. doi: 10.1016/0049-3848(93)90241-f.
5
In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.体外凝块溶解作为血栓对纤维蛋白溶解抵抗的潜在指标——在健康受试者中的研究及其与血液纤溶参数的相关性
Thromb Haemost. 1997 Apr;77(4):725-9.
6
Plasminogen, plasminogen activator, and platelets in the regulation of clot lysis. Reconstitution and patient studies.纤溶酶原、纤溶酶原激活物及血小板在凝块溶解调节中的作用。重建及患者研究。
J Lab Clin Med. 1982 Dec;100(6):986-96.
7
Platelet-bound prekallikrein promotes pro-urokinase-induced clot lysis: a mechanism for targeting the factor XII dependent intrinsic pathway of fibrinolysis.
Thromb Haemost. 1994 Mar;71(3):347-52.
8
Reduced in vitro clot lysis and release of more active platelet PAI-1 in polycythemia vera and essential thrombocythemia.真性红细胞增多症和原发性血小板增多症患者体外血块溶解减少,且释放出更具活性的血小板纤溶酶原激活物抑制因子-1。
Thromb Res. 1998 Apr 15;90(2):51-6. doi: 10.1016/s0049-3848(98)00005-x.
9
Increased plasma clot permeability and susceptibility to lysis are associated with heavy menstrual bleeding of unknown cause: a case-control study.血浆凝块通透性增加及对溶解的易感性与不明原因的月经过多相关:一项病例对照研究。
PLoS One. 2015 Apr 24;10(4):e0125069. doi: 10.1371/journal.pone.0125069. eCollection 2015.
10
Platelet protease nexin-1, a serpin that strongly influences fibrinolysis and thrombolysis.血小板蛋白酶素-1,一种对纤维蛋白溶解和溶栓有重要影响的丝氨酸蛋白酶抑制剂。
Circulation. 2011 Mar 29;123(12):1326-34. doi: 10.1161/CIRCULATIONAHA.110.000885. Epub 2011 Mar 14.